Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for people suffering from some retinal diseases.
Related Posts
Shell, BP and TotalEnergies Invest in Major Abu Dhabi LNG Project
European energy giants Shell, BP and TotalEnergies have signed deals to invest in Abu Dhabi’s Ruwais liquefied natural-gas project, set to boost the Gulf nation’s […]
Peloton Interactive Names Peter Stern as CEO; Narrows 1Q Losses
Peloton Interactive appointed Peter Stern as chief executive officer following a months-long search for a new leader to continue its turnaround efforts.
Novartis Lifts Sales Outlook on Key Drugs, Pipeline Portfolio
The pharma company raised its guidance on revenue growth from its key treatments and expected drug launches, and now anticipates annual currency-adjusted sales to grow […]